These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Opportunities and challenges for the development of pharmacological therapies for obesity treatment. Cawthorne MA Obes Rev; 2007 Mar; 8 Suppl 1():131-6. PubMed ID: 17316316 [No Abstract] [Full Text] [Related]
11. First in class, best in class or a wild card: who will dominate the anti-obesity medication market? Collins E; Beattie A; Ramagopalan SV; Pearson-Stuttard J J Comp Eff Res; 2024 Jul; 13(7):e240044. PubMed ID: 38808628 [No Abstract] [Full Text] [Related]
12. A big issue? Marnell T Br J Gen Pract; 2006 Jan; 56(522):57. PubMed ID: 16438818 [No Abstract] [Full Text] [Related]
13. National trends in the use and costs of anti-obesity medications in England 1998-2005. Srishanmuganathan J; Patel H; Car J; Majeed A J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061 [TBL] [Abstract][Full Text] [Related]
18. Employers, others not sold on new anti-obesity drugs. Reinke T Manag Care; 2012 Sep; 21(9):33-6. PubMed ID: 23050423 [No Abstract] [Full Text] [Related]
19. Africa finds drug giants guilty of excessive pricing. AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397 [No Abstract] [Full Text] [Related]
20. One pill makes you smaller: the demand for anti-obesity drugs. Cawley J; Rizzo JA Adv Health Econ Health Serv Res; 2007; 17():149-83. PubMed ID: 19548552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]